Kenneth A. Lock - Chief Commercial Officer at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth A. Lock since 12/22/2023

Holdings reported by Kenneth A. Lock for Arcutis Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 63.4K $225K $3.54 Mar 6, 2023 Direct
Stock Option (Right to Buy) 55.8K Mar 2, 2023 Direct Common Stock

Transactions reported by Kenneth A. Lock for Arcutis Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.